Evaluating CVD Medication Adherence Program in Low SES

Completed · Not applicable

Conditions studied: Cardiovascular Disease, Hypertension, Diabetes

In brief

The investigators propose to evaluate the implementation of an efficacious medication adherence program in a group at high risk for CVD. The program involves patients receiving/responding to e-reminders to take CVD medications via patient-selected technology \[mobile/web-based applications, short message service (SMS; text messaging), interactive voice response (IVR), or e-mail\] supported by a tailored, monthly, self-management program administered by either research staff or a case manager staff member from the Duke Outpatient Clinic via the telephone. This is a hybrid type II implementation science study.

Key facts

Study ID
NCT02375737
Run by
Duke University
People needed
100
Starts
2015-01-01
Expected to finish
2016-08-01
Last updated by the study team
2016-08-12

Who can join

Age: 21 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.